Autres langues Outlook Therapeutics, Inc.

Actions

OTLK

US69012T3059

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
8,6 ^USD	+1,18%		+2,02%	+9,14%

27/03	Les actions d'Outlook Therapeutics augmentent après le relèvement de la note de BTIG	MT
27/03	OUTLOOK THERAPEUTICS, INC. : BTIG réajuste son opinion à la hausse	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Outlook Therapeutics® to Present at the Retina World Congress 2024	02/05
Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase	29/04
Outlook Therapeutics Announces Closing of Private Placement of $5.0 Million	16/04
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million	15/04
Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	15/04
Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	15/04
Corporate Presentation: March 2024	28/03
North American Morning Briefing : Stocks Set for -2-	28/03
Outlook Therapeutics Shares Rise After BTIG Upgrade	27/03
Outlook Therapeutics Reports Secondary Share Offering	25/03
Outlook Therapeutics Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD	25/03
Sector Update: Health Care Stocks Ease Late Afternoon	22/03
Sector Update: Health Care Stocks Ease Friday Afternoon	22/03
Sector Update: Health Care Stocks Steady Pre-Bell Friday	22/03
Outlook Therapeutics Gets EMA Panel Positive Opinion for Wet AMD Treatment -- Shares Rise Pre-Bell	22/03
Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD	22/03
Outlook Therapeutics Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD	22/03
Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million	18/03
Outlook Therapeutics, Inc. announced that it has received $59.999961 million in funding from a group of investors	18/03
Outlook Therapeutics Announces Effective Date for 1-for-20 Reverse Stock Split	13/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Outlook Therapeutics, Inc.

Actions

OTLK

US69012T3059

Autres langues

Filtres